Sarah Elhourch1, Housna Arrouchi1, Nour Mekkaoui2, Younes Allou1, Fatima Ghrifi1, Loubna Allam1, Naima Elhafidi1,3, Lahcen Belyamani4, Azeddine Ibrahimi1, Naoual Elomri4, Rachid Eljaoudi1. 1. Medical Biotechnology Laboratory (MedBiotech), Bioinova Research Center, Rabat Medical & Pharmacy School, Mohammed Vth University, 10000 Rabat, Morocco. 2. Clinical Research and Epidemiology Biostatistics Laboratory, Rabat Medical & Pharmacy School, Mohammed Vth University in Rabat, 10000 Rabat, Morocco. 3. Immuno-Allergology Unit Children's Hospital, 10000 Rabat, Morocco. 4. Military Hospital Mohammed V, Rabat Medical & Pharmacy School, Mohammed Vth University in Rabat, 10000 Rabat, Morocco.
Abstract
BACKGROUND AND AIMS: Several studies have shown that genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) are highly associated with the development of type 2 diabetes mellitus (T2DM) and its associated complications in several populations. The aim of our study was to investigate the association of the rs7903146 (C/T) and rs12255372 (G/T) polymorphism in the TCF7L2 gene with the risk of developing T2DM in the Moroccan population. MATERIAL AND METHODS: A total of 150 T2DM patients and 100 healthy controls were recruited for various anthropometric, biochemical and genetic parameters. Genotyping was performed by using Real Time-PCR. The frequency of genotypes, alleles, anthropometric measures, glycemia, glycated hemoglobin (HbA1c) were evaluated in patients and control, while lipid profile was available only for T2DM group. RESULTS: Glycemia, HbA1c and body mass index (BMI) were significantly higher in T2DM group than control. Analysis of the distribution of the TCF7L2 rs7903146 genotype and allele revealed that the TT genotype was more frequent in T2DM group (24.0%) than in healthy controls (5%) (OR = 4.08, 95% confidence interval (CI = 1.95-11.80, p < 0.0001). The T allele was more frequent in diabetic patients (45.2%) than healthy control (34.5%) and it was associated with high risk of diabetes (OR = 2.13, 95% CI = 1.12-7.31, p = 0.005). The same results were found regarding rs12255372, TT genotype frequencies were 18,7% and 6.0% in T2DM and control group, respectively (OR = 3.11, 95% CI = 1.33-7.24, p = 0.004). The T allele was over-presented in diabetics compared to controls (45.3% and 38.0%, respectively) and increases the risk of T2DM (OR = 2.01, 95% CI = 1.04-3.10, p = 0.01). However, there was no significant difference between the three genotypes of rs7903146 and rs12255372 regarding age, BMI, glycemia, HbA1c and lipid profile. CONCLUSION: The present study confirmed a significant association of the TCF7L2 gene (rs7903146 (C/T) and rs12255372 (G/T) polymorphisms with a higher risk to T2DM in the Moroccan population. No significant difference in respect to anthropometric and metabolic parameters between different genotypes.
BACKGROUND AND AIMS: Several studies have shown that genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) are highly associated with the development of type 2 diabetes mellitus (T2DM) and its associated complications in several populations. The aim of our study was to investigate the association of the rs7903146 (C/T) and rs12255372 (G/T) polymorphism in the TCF7L2 gene with the risk of developing T2DM in the Moroccan population. MATERIAL AND METHODS: A total of 150 T2DM patients and 100 healthy controls were recruited for various anthropometric, biochemical and genetic parameters. Genotyping was performed by using Real Time-PCR. The frequency of genotypes, alleles, anthropometric measures, glycemia, glycated hemoglobin (HbA1c) were evaluated in patients and control, while lipid profile was available only for T2DM group. RESULTS: Glycemia, HbA1c and body mass index (BMI) were significantly higher in T2DM group than control. Analysis of the distribution of the TCF7L2rs7903146 genotype and allele revealed that the TT genotype was more frequent in T2DM group (24.0%) than in healthy controls (5%) (OR = 4.08, 95% confidence interval (CI = 1.95-11.80, p < 0.0001). The T allele was more frequent in diabeticpatients (45.2%) than healthy control (34.5%) and it was associated with high risk of diabetes (OR = 2.13, 95% CI = 1.12-7.31, p = 0.005). The same results were found regarding rs12255372, TT genotype frequencies were 18,7% and 6.0% in T2DM and control group, respectively (OR = 3.11, 95% CI = 1.33-7.24, p = 0.004). The T allele was over-presented in diabetics compared to controls (45.3% and 38.0%, respectively) and increases the risk of T2DM (OR = 2.01, 95% CI = 1.04-3.10, p = 0.01). However, there was no significant difference between the three genotypes of rs7903146 and rs12255372 regarding age, BMI, glycemia, HbA1c and lipid profile. CONCLUSION: The present study confirmed a significant association of the TCF7L2 gene (rs7903146 (C/T) and rs12255372 (G/T) polymorphisms with a higher risk to T2DM in the Moroccan population. No significant difference in respect to anthropometric and metabolic parameters between different genotypes.
Authors: C Marzi; C Huth; M Kolz; H Grallert; C Meisinger; H-E Wichmann; W Rathmann; C Herder; T Illig Journal: Horm Metab Res Date: 2007-01 Impact factor: 2.936
Authors: Cuilin Zhang; Lu Qi; David J Hunter; James B Meigs; JoAnn E Manson; Rob M van Dam; Frank B Hu Journal: Diabetes Date: 2006-09 Impact factor: 9.461
Authors: Coleen M Damcott; Toni I Pollin; Laurie J Reinhart; Sandra H Ott; Haiqing Shen; Kristi D Silver; Braxton D Mitchell; Alan R Shuldiner Journal: Diabetes Date: 2006-09 Impact factor: 9.461
Authors: J V van Vliet-Ostaptchouk; R Shiri-Sverdlov; A Zhernakova; E Strengman; T W van Haeften; M H Hofker; C Wijmenga Journal: Diabetologia Date: 2006-10-10 Impact factor: 10.122
Authors: Steve E Humphries; David Gable; Jackie A Cooper; Helen Ireland; Jeffrey W Stephens; Steven J Hurel; Ka Wah Li; Jutta Palmen; Michelle A Miller; Francesco P Cappuccio; Robert Elkeles; Ian Godsland; George J Miller; Philippa J Talmud Journal: J Mol Med (Berl) Date: 2006-12 Impact factor: 4.599
Authors: Ahmed Chetoui; Kamal Kaoutar; Soufiane Elmoussaoui; Kaltoum Boutahar; Abdesslam El Kardoudi; Fatiha Chigr; Mohamed Najimi Journal: Int Health Date: 2020-01-20 Impact factor: 3.131